BIOVICTA
ActiveThe computed 12-month bankruptcy probability of BIOVICTA is 1.8% (moderate). The 2024 annual accounts show negative equity (€-189k) and a net result of €-85k. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 14% of 2091 sector peers (fiscal year 2024). The company has been active since 2018 and the Belgian State Gazette contains no insolvency or warning signals.
Checked score
Score 2024
20
/ 100
Critical
The score weighs solvency, liquidity, profitability and financial development. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2023
Profitability1▲+1
Solvency0=
Growth32=
Track record100
Bankruptcy probability, 12 months
1.8%
Moderate
0%0.5%1.5%4%10%≥ 25%
No credit on open account
Liquidity short (current ratio 0.85 against 0.7 in 2023; short-term debt: 118.1% and cash: 4.8% of total assets), and equity is negative.
Credit advice for your own amount and term
Signals
Seven signals. The signal on the left, the evidence on the right.
+raises risk○neutral
raises risk · Annual accounts: weaker financial profile
The latest annual accounts show a weaker profile in solvency, result or liquidity than companies that stay afloat.
NBB · annual accounts 2024Solvency, return and age of the figures
Solvency
-31.8%
Return on assets
-14.4%
Age of the figures
21 mo
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 10
Relative position
BE, all sectors
reference
Sector 10
higher
← fewer bankruptcies
more bankruptcies →
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation dateAge against the risk zone
raises risk · Negative equity
The 2024 annual accounts show negative equity and a net loss.
NBB · annual accounts 2024Equity per financial year
18192021222324
2018 to 2024 · latest year €-189k
neutral · Filed after the deadline
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 12-08-2025, 12 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 7 filingsDeviation from the deadline
2025
not confirmed
2024
12 d late
2023
13 d early
2022
7 d early
2021
31 d late
2020
59 d late
2019
30 d early
← before the deadline
after the deadline →
Financials · fiscal year 2024, micro schema
Equity
€-189k▼ 82.7%
2023 · €-103k
2018: €-684
2019: €22k
2020: €-28k
2021: €26k
2022: €-35k
2023: €-103k
2018 → 2024
Total assets
€593k▲ 144%
2023 · €243k
2018: €82k
2019: €116k
2020: €349k
2021: €391k
2022: €310k
2023: €243k
2018 → 2024
Net result
€-85k▼ 25.5%
2023 · €-68k
2018: €-19k
2019: €23k
2020: €-49k
2021: €54k
2022: €-55k
2023: €-68k
2018 → 2024
Working capital
€-108k▼ 3.0%
2023 · €-104k
2018: €-684
2019: €21k
2020: €27k
2021: €88k
2022: €-38k
2023: €-104k
2018 → 2024
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20202021202220232024Trend
Equity€-28k-€26k€-35k€-103k▼ 193%€-189k▼ 82.7%
Operating result€-39k-€68k€-29k€-26k▲ 8.8%€-17k▲ 35.9%
Net result€-49k-€54k€-55k€-68k▼ 23.2%€-85k▼ 25.5%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result stays negative: a loss of €17k in 2024 against €26k in 2023; the loss shrinks.
Balance-sheet composition
2024 in colour, 2023 as the grey bar beneath
Assets €593k
Fixed assets
€296▼ 73.1%
Current assets
€593k▲ 145%
Key figures and ratios
EBITDA
€-16k▲
2023 · €-23k
Cash flow
€-85k▼
2023 · €-65k
Solvency
-31.8%▲
2023 · -42.5%
Current ratio
0.85▲
2023 · 0.70
Quick ratio
0.62▲
2023 · 0.24
Debt / equity
-4.14▼
2023 · -3.35
ROA
-14.4%▲
2023 · -28.0%
Interest coverage
-0.23▲
2023 · -0.56
Debt
€782k▲
2023 · €346k
Debt ≤ 1 year
€700k▲
2023 · €346k
Debt > 1 year
€81k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2024 against 2023
Balance sheet
Code20232024
Assets
Total assets20/58€243k€593k▲
Fixed assets21/28€1k€296▼
Tangible fixed assets22/27€1k€296▼
Furniture and vehicles24€1k€296▼
Current assets29/58€242k€593k▲
Stocks and contracts in progress3€158k€156k▼
Stocks30/36€158k€156k▼
Amounts receivable within one year40/41€61k€409k▲
Trade receivables40€35k€89k▲
Other amounts receivable41€25k€319k▲
Cash at bank and in hand54/58€23k€28k▲
Equity and liabilities
Total equity and liabilities10/49€243k€593k▲
Equity10/15€-103k€-189k▼
Contributions10/11€19k€19k=
Reserves13€2k€2k=
Non-distributable reserves130/1€2k€2k=
Reserves not available under the articles1311€2k€2k=
Profit (loss) carried forward14€-124k€-209k▼
Amounts payable17/49€346k€782k▲
Amounts payable after more than one year17-€81k
Financial debts170/4-€81k
Amounts payable within one year42/48€346k€700k▲
Current portion of amounts payable after more than one year42€663€20k▲
Financial debts43€61k€82k▲
Credit institutions430/8€61k€82k▲
Trade debts44€247k€570k▲
Suppliers440/4€247k€570k▲
Taxes, remuneration and social security45€15k€17k▲
Taxes450/3€15k€17k▲
Other amounts payable47/48€22k€11k▼
Income statement
Code20232024
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€3k€802▼
Gross operating margin9900€-23k€-16k▲
Operating profit (loss)9901€-26k€-17k▲
Financial income75/76B€103-
Recurring financial income75€103-
Financial charges65/66B€42k€69k▲
Recurring financial charges65€42k€69k▲
Profit (loss) for the period before taxes9903€-68k€-85k▼
Profit (loss) for the period9904€-68k€-85k▼
Profit (loss) for the period to be appropriated9905€-68k€-85k▼
Appropriation of the result
Profit (loss) to be appropriated9906€-124k€-209k▼
Profit (loss) brought forward from the previous period14P€-56k€-124k▼
The notes to these accounts (5 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
2025
12-08
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema · 12 days late
2024
31-12
Financial
Weakest financial yearnet €-85k
Net result drops to €-85k, the lowest in the series.
18-07
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2023
24-07
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema
2022
31-08
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema · 31 days late
2021
31-12
Financial
Back to profitnet €54k
Net result €54k after one loss-making year.
28-09
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema · 59 days late
2020
01-07
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema
2019
31-12
Financial
Back to profitnet €23k
Net result €23k after one loss-making year.
23-08
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema · 23 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Chaudfontaine · 1 establishment unit since 2018
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Rue Joseph Dupont 754053 ChaudfontaineGround area
1,849 m²
Building footprint
799 m²
Volume, LiDAR
3,425 m³
Parcel 62030A0116/00N000, Wallonia · tallest building 6.6 m, ±1 floor. Linked by address, not a title deed.
1 establishment unit
BIOVICTA
since 20182.275.547.447
1 parcel
Wallonia
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 62030A0116/00N000 | Wallonia | 1,848 m² | 1 · 799 m² | 6.6 m · 1 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Recognitions · licences · registrations
Food safety, FASFC
1 siteChaudfontaine2.275.547.447
Similar companies · same sector, comparable size
EQUI-NUTRI
BE 0885.643.850
Wellin · Eq €23k
Prolacta Belgium
BE 0771.722.496
Dilbeek · Eq €21k
WILD BOYS
BE 0701.895.067
Fexhe-le-Haut-Clocher · Eq €33k
Phytoresc Laboratories
BE 0790.817.640
Oudenaarde · Eq €18k
Pharmacie Manon
BE 0701.841.718
Walcourt · Eq €40k
Of 87 companies in sector 10860 we hold annual accounts for 47. 24 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company (pre-2019)
Founded22-03-2018
Fiscal year end31-12
Activities, NACEBEL
10860Manufacture of food products
10890Manufacture of food products
32500Manufacture of medical and dental instruments and supplies
46389Wholesale of other food products
46460Wholesale of pharmaceutical and medical goods
47730Retail sale of pharmaceutical products
Sources
Crossroads Bank for EnterprisesNational Bank · 7 filingsAddress and cadastre registers
Data from official sources, last processed on 16-09-2026. Scores and ratios are computed by Checked and are not a credit decision.
Contact details
2 entriesE-mail:info@comptarama.be
Phone:042877096